Power Law company profile

Nektar Therapeutics

Biotech & Life Sciences · San Carlos, United States · Founded 1990 · IPO 1994 Thoroughbred

← All companies

A public taster of the full Dealroom platform — request a demo to explore live financials, founders, funding history, and market intelligence.

Valuation

$2.60B

Market cap · Apr/2026

Revenue

$55M

Latest reported FY

Investors

1 investor on Nektar Therapeutics's cap table

Sourced from Dealroom's funding history. Tap any card for that investor's profile.

Series B+ 1 investor entered at this stage

Global footprint

Web traffic by country

51K monthly visits
across markets

🇺🇸 United States20.6%

🇬🇧 United Kingdom5.3%

🇨🇦 Canada4.5%

🇪🇸 Spain2.4%

🇫🇷 France2.2%

Top 5 markets shown

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Open in Dealroom Book a demo